These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33080148)

  • 1. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
    Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
    J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
    Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
    Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
    Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
    Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
    Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
    Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
    Kim M; Lee SM; Son IT; Park T; Oh BY
    Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
    Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
    J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
    Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
    ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
    Martin L; Gioulbasanis I; Senesse P; Baracos VE
    JPEN J Parenter Enteral Nutr; 2020 Feb; 44(2):227-238. PubMed ID: 31012128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of contrast phase on quantitative analysis of skeletal muscle and adipose tissue by computed tomography.
    Vedder IR; Levolger S; Dierckx RAJO; Viddeleer AR; Bokkers RPH
    Nutrition; 2024 Oct; 126():112492. PubMed ID: 39089132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between imaging-based body composition abnormalities and long-term mortality in patients with liver cirrhosis.
    Ren W; Zheng J; Yang S; Zhong J; Liu X; Liu X; Feng J; Wei T; Yang Y; Tie C; Hong C; Feng B; Huang R
    Eur J Radiol; 2024 Nov; 180():111707. PubMed ID: 39197272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
    Donnelly M; Driever D; Ryan ÉJ; Elliott JA; Finnegan J; McNamara D; Murphy I; Conlon KC; Neary PC; Kavanagh DO; O'Riordan JM
    Inflamm Bowel Dis; 2024 Sep; 30(9):1517-1528. PubMed ID: 37861366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
    Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
    Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.